Loading…
Lean Dreams LLC sold unapproved and misbranded compounded drug products (semaglutide and tirzepatide) over the internet by falsely claiming they contained "the same active ingredient" as FDA-approved drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. These misleading claims violated the Federal Food, Drug, and Cosmetic Act sections 502(a) and 502(bb), which prohibit false or misleading labeling and advertising for compounded drugs. The company's marketing implied its unapproved compounded products were equivalent to approved medications, thereby introducing misbranded drugs into interstate commerce in violation of the law.